A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Oncoinvent Solutions AS
Oncoinvent Solutions AS
Lumicell, Inc.
Seagen Inc.
Merck Sharp & Dohme LLC
Corcept Therapeutics
GE Healthcare
Oncoinvent Solutions AS
Arsenal Biosciences, Inc.
Hoffmann-La Roche
Genelux Corporation
Corcept Therapeutics
Boehringer Ingelheim
OncoNano Medicine, Inc.
Kazia Therapeutics Limited
Sichuan Clover Biopharmaceuticals, Inc.
Shanghai Yunying Medical Technology
Hoffmann-La Roche
Genelux Corporation
Sorrento Therapeutics, Inc.
Boston Scientific Corporation
Novartis
Ipsen
Eli Lilly and Company
Celgene
Celgene
Hoffmann-La Roche
Janssen Research & Development, LLC
Hoffmann-La Roche
Neovii Biotech
Pierian Biosciences
Boehringer Ingelheim
Orano Med LLC
MEI Pharma, Inc.
Morphotek
OvaGene Oncology, Inc.
CritiTech, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Precision Therapeutics
Facet Biotech
Novartis
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Pfizer